Inventor · disambiguated record
Robert Andrew Heald
Also filed as: HEALD ROBERT · HEALD ROBERT A · HEALD ROBERT ANDREW
45 granted patents·15 pending applications·394 citations·filing 2001–2025
98Inventor score
Top patents by PatentIndex Score
60 records- 0198US8785626B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Jul 22, 2014·54 cites·4 claims
- 0297US8343955B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2012·Granted Jan 1, 2013·39 cites·31 claims
- 0396US9650393B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2016·Granted May 16, 2017·20 cites·23 claims
- 0496US8673952B2Benzoxepin PI3K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2012·Granted Mar 18, 2014·42 cites·22 claims
- 0596US8242104B2Benzoxazepin P13K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2010·Granted Aug 14, 2012·53 cites·33 claims
- 0695US8586574B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2012·Granted Nov 19, 2013·19 cites·2 claims
- 0795US8263633B2Benzoxepin PI3K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2010·Granted Sep 11, 2012·29 cites·4 claims
- 0894US10851091B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2018·Granted Dec 1, 2020·5 cites·3 claims
- 0993US11760753B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2020·Granted Sep 19, 2023·2 cites·17 claims
- 1092US10112932B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2017·Granted Oct 30, 2018·8 cites·9 claims
- 1191US8492427B2Isoindolones derivatives as MEK kinase inhibitors and methods of useGANCIA EMANUELA·Filed 2009·Granted Jul 23, 2013·36 cites·13 claims
- 1290US2025388599A1Tricyclic pi3k inhibitor compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 1389US2025197386A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 1488US2025326745A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 1587US10023558B2CompoundsCHIESI FARM SPA·Filed 2017·Granted Jul 17, 2018·6 cites·20 claims
- 1686US9890152B2Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2015·Granted Feb 13, 2018·7 cites·29 claims
- 1786US9802919B1CompoundsCHIESI FARM SPA·Filed 2017·Granted Oct 31, 2017·5 cites·14 claims
- 1886US2024199594A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 1985US9546178B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2015·Granted Jan 17, 2017·3 cites·8 claims
- 2085US7923456B25-anilinoimidazo[1,5-a]-pyridines inhibitors of MEK kinaseGENENTECH INC·Filed 2009·Granted Apr 12, 2011·7 cites·17 claims
- 2184US9951064B2Azaindazole compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2016·Granted Apr 24, 2018·5 cites·15 claims
- 2284US9409870B2CompoundsCHIESI FARM SPA·Filed 2015·Granted Aug 9, 2016·5 cites·12 claims
- 2382US9023855B2CompoundsCHIESI FARMA SPA·Filed 2014·Granted May 5, 2015·2 cites·20 claims
- 2482US8883799B2Tricyclic PI3K inhibitor compounds and methods of useDOTSON JENNAFER·Filed 2011·Granted Nov 11, 2014·6 cites·25 claims
- 2581US7115619B2N8, N13 -disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agentsCANCER REC TECH LTD·Filed 2001·Granted Oct 3, 2006·14 cites·58 claims
- 2680US9643980B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2016·Granted May 9, 2017·3 cites·21 claims
- 2780US8952043B2Benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Feb 10, 2015·3 cites·21 claims
- 2879US8691826B2CompoundsBLENCH TOBY JONATHAN·Filed 2012·Granted Apr 8, 2014·5 cites·17 claims
- 2978US9670228B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Jun 6, 2017·1 cites·4 claims
- 3078US8653089B2Heterocyclic compounds and methods of useHEALD ROBERT·Filed 2012·Granted Feb 18, 2014·5 cites·3 claims
- 3176US2022348593A1Tricyclic pi3k inhibitor compounds and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 3275US9546182B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Jan 17, 2017·2 cites·8 claims
- 3374US9206174B25-anilinoimidazopyridines and methods of useGENENTECH INC·Filed 2013·Granted Dec 8, 2015·1 cites·2 claims
- 3470US10065970B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Sep 4, 2018·1 cites·18 claims
- 3569US8841462B2Bicyclic heterocycles as MEK kinase inhibitorsHEALD ROBERT A·Filed 2009·Granted Sep 23, 2014·2 cites·19 claims
- 3668US8486963B2Azaindolizines and methods of usePRICE STEPHEN·Filed 2008·Granted Jul 16, 2013·1 cites·17 claims
- 3768US8293763B28-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agentsPRICE STEPHEN·Filed 2008·Granted Oct 23, 2012·1 cites·17 claims
- 3868US8288408B25-anilinoimidazopyridines and methods of usePRICE STEPHEN·Filed 2011·Granted Oct 16, 2012·1 cites·3 claims
- 3966US9175009B2Benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Nov 3, 2015·0 cites·5 claims
- 4066US2019330235A1Tricyclic p13k inhibitor compounds and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 4165US9198918B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Dec 1, 2015·0 cites·12 claims
- 4263US2017210733A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 4360US9090628B2Benzoxazepin compounds selective for PI3K P110 delta and methods of useHEFFRON TIMOTHY·Filed 2012·Granted Jul 28, 2015·1 cites·6 claims
- 4459US2017233407A1Tricyclic p13k inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Application pending·0 cites
- 4555US2024425511A1Heterocyclic compounds for use in the treatment of cancerARTIOS PHARMA LTD·Filed 2022·Application pending·0 cites
- 4655US2025230165A1Heterocyclic compounds for use in the treatment of cancerARTIOS PHARMA LTD·Filed 2022·Application pending·0 cites
- 4755US2025241926A1Heterocyclic compounds for use in the treatment of cancerARTIOS PHARMA LTD·Filed 2022·Application pending·0 cites
- 4854US9365577B2Pyrimidinone compounds as human neutrophil elastase inhibitorsCHIESI FARMA SPA·Filed 2013·Granted Jun 14, 2016·0 cites·16 claims
- 4954US2012309765A15-anilinoimidazopyridines and methods of usePRICE STEPHEN·Filed 2012·Application pending·0 cites
- 5050US10435414B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2018·Granted Oct 8, 2019·0 cites·23 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →